Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Ian Edward Stevens has worked on the following 28 EPO patent applications which have been published in the last five years:

EP11721710

FAT BLEND

IPC classification:
A23D 9/00, A23G 1/38
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11715112

POLYCYCLIC TETRACYCLINE COMPOUNDS

IPC classification:
A61K 31/403, A61K 31/473, A61K 31/551, A61P 31/00, C07D 209/58, C07D 221/18, C07D 243/10, C07D 405/04, C07D 405/06, C07D 487/04
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11716163

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS AND A EGFR INHIBITOR

IPC classification:
A61K 31/4196, A61K 31/675, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11719104

CATALYST COMPOSITION FOR PRODUCING HIGH Mz/Mw POLYOLEFINS

IPC classification:
C08F 210/16
Applicant:
Chevron Phillips Chemical Company LP
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP11725836

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND AND A TOPOISOMERASE II INHIBITOR

IPC classification:
A61K 31/404, A61K 31/4196, A61K 31/423, A61K 31/7004, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11720029

EDIBLE OIL COMPOSITION

IPC classification:
A23D 9/00, A23D 9/02, A23D 9/05
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP11761245

NOVEL CATALYST SYSTEMS AND POLYMER RESINS HAVING IMPROVED BARRIER PROPERTIES

IPC classification:
C07F 17/00, C08F 4/69, C08F 10/02
Applicant:
Chevron Phillips Chemical Company LP
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11764914

NOVEL CATALYST SYSTEMS AND POLYMER RESINS HAVING IMPROVED BARRIER PROPERTIES

IPC classification:
B01D 71/26, B01J 31/00, C07F 17/00, C08F 4/69, C08F 4/78, C08F 10/02, C08J 5/18
Applicant:
Chevron Phillips Chemical Company LP
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP11755485

POLYMER RESINS HAVING IMPROVED BARRIER PROPERTIES AND METHODS OF MAKING SAME

IPC classification:
C08J 5/18, C08L 23/04
Applicant:
Chevron Phillips Chemical Company LP
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11781405

COMPOSITIONS AND METHODS FOR MODULATING METABOLISM

IPC classification:
A61K 31/00, A61K 31/5517, A61K 31/69, A61K 31/713, A61P 1/16, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/10, A61P 9/12, C12N 15/09
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP11781410

MALE CONTRACEPTIVE COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/5517, A61P 15/00, C07D 471/00, C07D 495/14
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP12700765

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH PROTEASOME INHIBITORS

IPC classification:
A61K 31/4196, A61K 31/5377, A61K 31/675, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11859661

UP-CONVERSION DEVICES WITH A BROAD BAND ABSORBER

IPC classification:
H01L 31/10, H01L 33/02
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11859925

INFRARED PASS VISIBLE BLOCKER FOR UPCONVERSION DEVICES

IPC classification:
G01J 1/02, H01L 31/09
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11719114

USE OF BIS [THIOHYDRAZIDE AMIDE]COMPOUNDS SUCH AS ELESCLOMOL FOR TREATING CANCERS

IPC classification:
A61K 31/00, A61K 31/18, A61K 31/195, A61K 31/337, A61K 31/555, A61P 35/00, A61P 35/02
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722587

METHOD AND DEVICE FOR REMOVING PARTICLES FROM LIQUID AND PLACING THEM INTO A HOLDING DEVICE

IPC classification:
B01L 3/02, G01N 35/10
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION WITHDRAWN
EP12724523

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORS

IPC classification:
A61K 31/405, A61K 31/4196, A61K 31/4535, A61K 31/497, A61K 31/506, A61K 31/519, A61K 31/551, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12724504

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MEK INHIBITORS

IPC classification:
A61K 31/166, A61K 31/277, A61K 31/352, A61K 31/416, A61K 31/4196, A61K 31/675, A61K 35/00, A61K 45/06
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12723814

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MTOR/PI3K INHIBITORS

IPC classification:
A61K 31/4196, A61K 31/675, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11186691

Renin Inhibitors

IPC classification:
A61K 31/445, A61K 31/453, A61P 9/00, C07D 211/22, C07D 211/26, C07D 401/12, C07D 405/12, C07D 407/12, C07D 409/06, C07D 417/06
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825553

PHOTODETECTOR AND UPCONVERSION DEVICE WITH GAIN (EC)

IPC classification:
H01L 31/101
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP11751491

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

IPC classification:
C07D 203/04, C07D 203/06, C07D 207/337, C07D 231/12, C07D 233/64, C07D 249/08, C07D 257/04, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/06, C07D 403/12, C07D 405/12, C07D 417/04, C07D 417/12
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12789725

EXPANDABLE DEVICE FOR TISSUE COLLECTION FROM AN AERODIGESTIVE BODY LUMEN

IPC classification:
A61B 10/02, A61B 10/04, A61B 17/3207
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13275192

Fat composition

IPC classification:
A23D 9/00, A23D 9/02, C11B 7/00, C11C 3/10
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13275202

Fat composition for improved body fat distribution

IPC classification:
A23D 9/00, A23D 9/02, A23L 1/29, A61K 31/215, A61P 3/04
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11781299

THERAPEUTIC REGIMENS

IPC classification:
A61K 31/137, A61P 5/24
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11760643

HSP90 INHIBITORS FOR TREATING NON-SMALL CELL LUNG CANCERS IN WILD-TYPE EGFR AND/OR KRAS PATIENTS

IPC classification:
A61K 31/404, A61K 31/4196, A61K 31/423, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755483

NOVEL CATALYST SYSTEMS AND METHODS OF MAKING AND USING SAME

IPC classification:
C08F 210/16
Applicant:
Chevron Phillips Chemical Company LP
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature